BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21697527)

  • 1. Leveraging crowdsourcing to facilitate the discovery of new medicines.
    Norman TC; Bountra C; Edwards AM; Yamamoto KR; Friend SH
    Sci Transl Med; 2011 Jun; 3(88):88mr1. PubMed ID: 21697527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The precompetitive space: time to move the yardsticks.
    Norman T; Edwards A; Bountra C; Friend S
    Sci Transl Med; 2011 Mar; 3(76):76cm10. PubMed ID: 21451121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public-private partnerships to revitalize psychiatric drug discovery.
    Brady LS; Potter WZ
    Expert Opin Drug Discov; 2014 Jan; 9(1):1-8. PubMed ID: 24308355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How academic labs can approach the drug discovery process as a way to synergize with big pharma.
    Loregian A; Palù G
    Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is pharma running out of brainy ideas?
    Miller G
    Science; 2010 Jul; 329(5991):502-4. PubMed ID: 20671165
    [No Abstract]   [Full Text] [Related]  

  • 6. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public-private partnerships for health--what does the evidence say?
    Thomason J; Rodney A
    P N G Med J; 2009; 52(3-4):166-78. PubMed ID: 21877579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Innovative Medicine Initiative (IMI)].
    Bril A; Canet E
    Med Sci (Paris); 2008 Oct; 24(10):885-90. PubMed ID: 18950588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crowdsourcing in pharma: a strategic framework.
    Bentzien J; Bharadwaj R; Thompson DC
    Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicines discovery in the 21st century: the case for a stakeholder corporation.
    Dixon J; England P; Lawton G; Machin P; Palmer A
    Drug Discov Today; 2010 Sep; 15(17-18):700-3. PubMed ID: 20678583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of public-private partnerships in addressing the biomedical innovation challenge.
    Said M; Zerhouni E
    Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public-private partnership: from there to here.
    Croft SL
    Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perestroika in pharma: evolution or revolution in drug development?
    FitzGerald GA
    Mt Sinai J Med; 2010; 77(4):327-32. PubMed ID: 20687177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public-Private Partnerships in the health sector: the Danish experience.
    Vrangbaek K
    Health Econ Policy Law; 2008 Apr; 3(Pt 2):141-63. PubMed ID: 18634625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional drug-discovery model ripe for reform.
    Cressey D
    Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796
    [No Abstract]   [Full Text] [Related]  

  • 17. Reinventing bioinnovation.
    Kaitin KI; Honig PK
    Clin Pharmacol Ther; 2013 Sep; 94(3):279-83. PubMed ID: 23963211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.
    Zhang Z; Jia M; Wan D
    Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open PHACTS: semantic interoperability for drug discovery.
    Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
    Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning.
    Janero DR
    Expert Opin Drug Discov; 2014 Nov; 9(11):1265-79. PubMed ID: 25162124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.